跳至主要内容
临床试验/CTRI/2019/06/019604
CTRI/2019/06/019604招募中未知

Risk prediction for Contrast Induced Nephropathy in patients with renal impairment

GE Healthcare Limited0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
招募中

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

入选标准

  • All consecutive patients aged 18 to 80 years, who undergo PCI in the study sites can be enrolled into the study, if their GFR is 15- 60ml/min/1.73m2, in whom Iodixanol is the contrastmedia of choice. The screening tests required for the study must be performed in all patients.

排除标准

  • Evidence of acute renal failure before PCI, patients on regular dialysis, cardiogenic shock, patients who were exposed to contrast media within 14 days, patients exposed to nephrotoxic medication within 48hours of the procedure, patients requiring intra-aortic balloon pump (IABP) support and patients who developed PCI related complications will be ex¬cluded.

研究者

相似试验